Fig. 2.

Survival curves and cumulative incidence of serious adverse events in the per-protocol analysis. Kaplan–Meier estimates of all-cause mortality ( A ) and cumulative incidence of serious adverse events ( B ) for all patients grouped according to whether the treating general practitioner followed the specialist's advice (adherence group). All other patients in both intervention and control groups were included in the nonadherence group.